Evidence map›Paper›PMID 42734682›Full record

ArticleJournal of molecular modeling2026

Membrane interactions and pore stability of aurein 1.2 and LLAA in single- and multi-peptide systems revealed by coarse-grained molecular dynamics simulations.

Roshanak Ansarihaghi

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Roshanak AnsarihaghiDepartment of Biological Sciences, Department of Biophysics, Institute for Advanced Studies in Basic Sciences, Zanjan, 45137-66731, Iran. roshanak.ansari@ut.ac.ir.ORCID https://orcid.org/0009-0000-9113-2815

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextAurein 1.2 is a short cationic antimicrobial peptide secreted by the Australian tree frog Litoria aurea. In this study, we investigated the membrane interactions of aurein 1.2 and its analog LLAA in single- and multi-peptide systems using model bacterial-like and eukaryotic-like lipid bilayers. LLAA exhibited stronger membrane interactions and deeper insertion than aurein, particularly in the bacterial-like membrane models. The simulations further indicated that peptide dissociation from aggregates was generally associated with increased membrane insertion. In pre-formed pore simulations, LLAA pore assemblies rapidly disassembled, whereas aurein pore assemblies remained stable for longer periods, particularly in the bacterial-like membrane models. These findings suggest that differences in peptide sequence and charge distribution are associated with distinct membrane insertion behavior, peptide organization, and the stability of pre-formed pore assemblies in the membrane models investigated.

methodsCoarse-grained molecular dynamics simulations were performed using the MARTINI force field with the polarizable water model. Simulations were carried out with GROMACS for systems containing single peptides, five-peptide membrane insertion systems, and pre-formed pore assemblies in POPC, DPPC, and POPE/POPG bilayers. Peptide insertion, orientation, electrostatic interactions, clustering, pre-formed pore stability, and water occupancy were analyzed using GROMACS analysis tools together with custom VMD Tcl, Python, and C++ scripts.

Indexed as

Antimicrobial Cationic PeptidesCell MembraneLipid BilayersMolecular Dynamics SimulationAnimalsAntimicrobial Cationic Peptidesaurein 1.2 peptideLipid BilayersAntimicrobial peptidesAurein 1.2Coarse-grained simulationLLAAMembrane interactionsMolecular dynamics simulation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.